Home > Industries > Private Equity and Venture Capital
Private Equity and Venture Capital
We lead companies to capital

Investors want to find deals and close them. Companies need capital to keep moving their businesses forward. Both want opportunities to connect with each other. Once they match their interests, they need experienced legal counsel who possess strong business acumen, who are prepared to work cooperatively to get deals done and who share their driving desire to close deals quickly and efficiently.

Attorneys in Saul Ewing Arnstein & Lehr’s Private Equity/Venture Capital Practice structure innovative, tax-advantaged deals. When a group of management employees learned of an opportunity to buy a division of a large international conglomerate, for instance, the Firm’s attorneys identified investors and helped the employees raise the capital to fund the acquisition. With the Firm’s support, the new owners turned around the company and sold it to a public company for a six times return on the initial investment – all in just three years.

The members of the Private Equity/Venture Capital team are especially adept at transactions involving investments into corporations and operating company LLCs. The team is connected with the private equity, venture capital and technology sectors throughout Saul Ewing Arnstein & Lehr’s 15 offices that stretch down the East Coast from Boston to Miami and extend into the Midwest by way of Chicago. These connections have led to mutually beneficial relationships between both early and later stage companies with private equity and venture capital funds, angel investors, individual investors, state agencies and other sources of funding throughout the region.

Saul Ewing Arnstein & Lehr’s Private Equity/Venture Capital Practice has experience advising:

  • Early and later stage companies in diverse industries, including software, IT, computer hardware, biotechnology, medical device, pharmaceutical, manufacturing, environmental and energy
  • Large and mid-market private equity funds and sponsors
  • Lenders in private financings involving mezzanine debt
  • Venture funds
  • Angel groups and super-angels
  • Individual investors
  • Family offices

 

 

My attorney’s ‘in-house perspective’ makes her quicker on the uptake when it comes to identifying the business risk of a legal decision. She also knows us and our business people and communicates with the right finesse.

Experience

Saul Ewing Arnstein & Lehr attorneys have handled these select transactions involving private equity/venture capital:

  • Represented Federal Data Systems in the acquisition of the counterintelligence and intelligence business unit of Intelligent Decisions for an undisclosed amount and in securing an equity investment from Chart Capital and senior bank financing to fund the acquisition.
  • Represented Patriot Capital in their investment of subordinated debt and equity in support of Guardian Capital Partners' acquisition of Carson-Dellosa Publishing, LLC.
  • Represented NewSpring SBIC Mezzanine Capital II, L.P. in acquiring controlling interest in Zentech Manufacturing, a Maryland-based manufacturing firm. The deal included 1) an asset purchase; 2) a senior bank loan; 3) a mezzanine subordinated debt loan to the company; and 4) a Series A preferred equity investment.
  • Represented Spring Capital Partners III, L.P. in a debt and equity investment in HomeCentris Healthcare, LLC through the issuance of a $2.25 million mezzanine loan and the purchase of about 10 percent of the preferred units of HomeCentris Healthcare, LLC.
  • Represented Grotech Ventures II, L.P. and Harbert Venture Partners III, L.P. in a $6 million Series A Preferred venture capital investment in Healthcare Interactive, Inc., a Maryland-based healthcare technology company.
  • Represented an emerging growth internet company in the retail automotive industry in a $1.5 million equity raise.
  • Represented NewSpring Capital and co-investor Camden Partners in a $13 million Series A and A-1 financing round in Paragon Bioservices, Inc. Paragon is a Baltimore-based contract research organization whose focus is the manufacturing of biopharmaceuticals.
  • Acted as Maryland co-counsel with Skadden Arps on corporate and litigation matters in defending Commonwealth REIT, a multi-billion dollar office REIT, in a hostile proxy fight initiated by Corvex Management LP and Related Fund Management LLC.
  • Represented private equity firm ABS Capital Partners in the recapitalization of Payformance Corporation.
  • Represented the members of Ellicott Dredge Enterprises, LLC in the sale of a substantial portion of the membership interests to Markel Ventures, Inc.
  • Represented Rohr International Dredge Holdings, Inc., a subsidiary of Ellicott Dredge Enterprises, in the acquisition of the assets of IDRECO GmbH.
  • Served as special government contracts’ counsel for PharmAthene, Inc., a leading biodefense company specializing in the development and commercialization of medical countermeasures against chemical and biological terrorism in its $45 million acquisition of the vaccines business of Avecia Biologies Ltd., a privately owned company in Manchester, England.
  • Represented a Baltimore-based biotechnology company in a $2 million offering of Series A Preferred Units of limited liability company membership interests.
  • Represented Syntec LLC in a Series A preferred stock capital raising transaction and in the purchase of a division of Tenax Corporation and subsequent sale to a public company three years later.
  • Represented Inflection Point Ventures and Liquid Capital in a $4 million Series A and bridge loan transaction.

Recognition

The group includes attorneys who have been named to the following lists:

  • Chambers - Corporate M&A and Private Equity

    Chambers and Partners uses a team of more than 140 researchers to rank lawyers on the basis of their legal knowledge and experience, their ability, their effectiveness and their client-service.

  • Super Lawyers

    Super Lawyers selects attorneys using a patented multiphase selection process, utilizing 12 indicators of peer recognition and professional achievement.

  • The Best Lawyers in America

    Inclusion in Best Lawyers is based entirely on peer review, employing a sophisticated, conscientious, rational, and transparent survey process designed to elicit meaningful and substantive evaluations of the quality of legal services.

  • Franchise Law BTI Client Services All-Star Team – M&A All Star

    Each year, BTI Consulting Group reaches out to a sample of legal decision makers at large organizations with $1 billion or more in revenue. BTI Client Service All-Stars draws on data collected in BTI’s ongoing Annual Survey of General Counsel.

Trade Groups & Associations
  • Maryland Incubator Company of the Year Awards
  • MIT Enterprise Forum
  • Pittsburgh Venture Capital Association
  • Allegheny Conference Regional Investor
  • Southeastern Economic Development Counsel of Pennsylvania